Group One Trading
BPMC

Group One Trading’s Blueprint Medicines BPMC Stock Holding History

Group One Trading’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-73,300
Closed -$9.4M – 8433
2025
Q2 		$9.4M Buy
73,300
+17,400
+31% +$1.81M 0.02% 847
2025
Q1 		$4.95M Sell
55,900
-40,800
-42% -$3.98M 0.01% 1086
2024
Q4 		$8.43M Sell
96,700
-25,500
-21% -$2.34M 0.02% 814
2024
Q3 		$11.3M Buy
122,200
+27,000
+28% +$2.68M 0.03% 552
2024
Q2 		$10.3M Buy
95,200
+34,300
+56% +$3.43M 0.04% 437
2024
Q1 		$5.78M Sell
60,900
-95,300
-61% -$8.17M 0.02% 747
2023
Q4 		$14.4M Buy
156,200
+52,300
+50% +$3.39M 0.04% 487
2023
Q3 		$5.22M Buy
103,900
+6,700
+7% +$358K 0.02% 924
2023
Q2 		$6.14M Buy
97,200
+49,500
+104% +$2.69M 0.02% 815
2023
Q1 		$2.15M Buy
47,700
+17,300
+57% +$779K 0.01% 1463
2022
Q4 		$1.33M Buy
30,400
+14,200
+88% +$681K ﹤0.01% 2173
2022
Q3 		$1.07M Buy
16,200
+15,500
+2,214% +$996K ﹤0.01% 2520
2022
Q2 		$35K Buy
+700
New +$41K ﹤0.01% 5859
2022
Q1 		– Sell
-15,400
Closed -$1.65M – 8042
2021
Q4 		$1.65M Sell
15,400
-900
-6% -$94.1K ﹤0.01% 2816
2021
Q3 		$1.68M Sell
16,300
-3,300
-17% -$307K ﹤0.01% 2844
2021
Q2 		$1.72M Buy
19,600
+18,700
+2,078% +$1.71M ﹤0.01% 2820
2021
Q1 		$88K Sell
900
-14,800
-94% -$1.48M ﹤0.01% 5767
2020
Q4 		$1.76M Sell
15,700
-9,100
-37% -$959K ﹤0.01% 2157
2020
Q3 		$2.3M Sell
24,800
-7,500
-23% -$578K 0.01% 1486
2020
Q2 		$2.52M Buy
32,300
+9,100
+39% +$615K 0.01% 1296
2020
Q1 		$1.36M Sell
23,200
-2,200
-9% -$142K 0.01% 1295
2019
Q4 		$2.04M Buy
25,400
+11,700
+85% +$876K 0.01% 1272
2019
Q3 		$1.01M Buy
13,700
+13,600
+13,600% +$1.18M 0.01% 1734
2019
Q2 		$9K Buy
+100
New +$8.25K ﹤0.01% 4444
2019
Q1 		– Sell
-10,400
Closed -$561K – 4819
2018
Q4 		$561K Sell
10,400
-4,500
-30% -$274K ﹤0.01% 1917
2018
Q3 		$1.16M Sell
14,900
-100
-0.7% -$6.95K 0.01% 1583
2018
Q2 		$952K Buy
15,000
+14,900
+14,900% +$1.19M 0.01% 1773
2018
Q1 		$9K Sell
100
-1,000
-91% -$86.2K ﹤0.01% 4341
2017
Q4 		$83K Buy
+1,100
New +$77.4K ﹤0.01% 3460
2017
Q2 		– Sell
-2,100
Closed -$84K – 4750
2017
Q1 		$84K Buy
+2,100
New +$75.2K ﹤0.01% 3083
2016
Q4 		– Sell
-2,600
Closed -$77K – 4420
2016
Q3 		$77K Buy
2,600
+1,000
+63% +$24.8K ﹤0.01% 3087
2016
Q2 		$32K Sell
1,600
-800
-33% -$14.5K ﹤0.01% 3557
2016
Q1 		$43K Hold
2,400
– – ﹤0.01% 3339
2015
Q4 		$63K Buy
+2,400
New +$54K ﹤0.01% 3278

Other funds holding BPMC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Group One Trading's BPMC Position: Q2 2025 in Review

Group One Trading sold out of Blueprint Medicines (BPMC) in Q2 2025, closing a stake of 11,452 shares — an estimated $1.19M sold.

Group One Trading first reported a position in BPMC in Q1 2016 and held it in 23 quarters. The position peaked at $4.67M in Q3 2024. 354 funds tracked by Wall St. Rank hold BPMC as of Q2 2025.

  • Group One Trading reported no remaining Blueprint Medicines position as of Q2 2025 after selling out during the quarter.
  • Group One Trading sold 11,452 Blueprint Medicines shares in Q2 2025, an estimated $1.19M.
  • Group One Trading first reported a position in Blueprint Medicines in Q1 2016 and held it in 23 quarters.
  • Group One Trading's Blueprint Medicines position peaked at $4.67M in Q3 2024.
  • 354 funds tracked by Wall St. Rank held Blueprint Medicines as of Q2 2025.

Based on Group One Trading's 13F filing for Q2 2025, filed 14 Aug 2025.